Intensity of malaria transmission and the evolution of drug resistance

Acta Tropica

Volumn 94, Issue 3 SPEC. ISS., 2005, Pages 218-229

  Hastings, Ian M ^a   Watkins, William M ^b  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Drug resistance; Epidemiology; Intensity of transmission; Malaria

Indexed keywords

DISEASE TRANSMISSION; DRUG RESISTANCE; MALARIA;

ARTICLE; DRUG TOLERANCE; EPIDEMIOLOGICAL DATA; GENETIC CODE; HEALTH SURVEY; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNITY; MALARIA; NONHUMAN; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM;

EID: 19344365271     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2005.04.003     Document Type: Article

References (40)

1. T.J.C. Anderson, R.E.L. Paul, C.A. Donnelly, and K.P. Day Do malaria parasites mate non-randomly within the mosquito mid gut? Genet. Res. 75 2000 285 296
2. T.J.C. Anderson, B. Haubold, J.T. Williams, J.G. Estrada-Franco, L. Richardson, R. Mollinedo, M. Bockarie, J. Mokili, S. Mharakurwa, N. French, J. Whitworth, I.D. Velez, A.H. Brockman, F. Nosten, M.U. Ferreira, and K.P. Day Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum Mol. Biol. E 17 2000 1467 1482
3. D.E. Arnot Clone multiplicity of Plasmodium falciparum infections in individuals exposed to variable levels of disease transmission Trans. R. Soc. Trop. Med. Hyg. 92 1998 580 585
4. J.F. Cortese, A. Caraballo, C.E. Contreras, and C.V. Plowe Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America J. Infect. Dis. 186 2002 999 1006
5. A.P. Cross, and B. Singer Modelling the development of resistance of Plasmodium falciparum to anti-malarial drugs Trans. R. Soc. Trop. Med. Hyg. 85 1991 349 354
6. C.F. Curtis, and L.N. Otoo A simple model of the build-up of resistance to mixtures of anti-malarial drugs Trans. R. Soc. Trop. Med. Hyg. 80 1986 889 892
7. C. Dye, and B.G. Williams Multigenic drug resistance among inbred malaria parasites Proc. R. Soc. London Ser. B 264 1997 61 67
8. I.M. Hastings A model for the origins and spread of drug resistant malaria Parasitology 115 1997 133 141
9. I.M. Hastings Modelling parasite drug resistance: lessons for management and control strategies Trop. Med. Int. Health 6 2001 883 890
10. I.M. Hastings Malaria control and the evolution of drug resistance: an intriguing link Trends Parasitol. 19 2003 70 73
11. I.M. Hastings The epidemiology of re-emerging malaria J. Parasitol. 89 2003 S62 S68
12. Hastings, I.M., in press. The origins of antimalarial drug resistance. Trends Parasitol.
13. I.M. Hastings, P.G. Bray, and S.A. Ward A requiem for chloroquine Science 298 2002 74 75
14. I.M. Hastings, and U. D'Alessandro Modelling a predictable disaster: the rise and spread of drug-resistant malaria Parasitol. Today 16 2000 340 347
15. I.M. Hastings, and M.J. Mackinnon The emergence of drug-resistant malaria Parasitology 117 1998 411 417
16. I.M. Hastings, W.M. Watkins, and N.J. White The evolution of drug resistant malaria; the role of drug elimination half-life Phil. Trans. R. Soc. London Ser. B 357 2002 505 519
17. W.G. Hill, H.A. Babiker, L.C. Ranford-Cartwright, and D. Walliker Estimation of inbreeding coefficients from genotypic data on multiple alleles, and application to estimation of clonality in malarial parasites Genet. Res. 65 1995 53 61
18. S. Looareesuwan, C. Viravan, H.K. Webster, D.E. Kyle, and C.J. Canfield Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand Am. J. Trop. Med. Hyg. 54 1996 62 66
19. C. Luxemburger, F. Nosten, D.E. Kyle, L. Kiricharoen, T. Chongsuphajaisiddhi, and N.J. White Clinical features cannot predict a diagnosis of malaria or differentiate the infecting species in children living in an area of low transmission Trans. R. Soc. Trop. Med. Hyg. 92 1998 45 49
20. M.J. Mackinnon Erratum Proc. R. Soc. London B 246 1997 189
21. M.J. Mackinnon Survival probabilities of drug resistant mutants in malaria parasites Proc. R. Soc. London Ser. B 264 1997 53 59
22. S. Nair, J.T. Williams, A. Brockman, L. Paiphun, M. Mayxay, P.N. Newton, J.-P. Guthman, F.M. Smithuis, T.T. Hien, N.J. White, F. Nosten, and T.J.C. Anderson A selective sweep driven by pyrimethamine treatment in SE Asian malaria parasites Mol. Biol. E 20 2003 1526 1536
23. A.M. Nzila, E. Nduati, E.K. Mberu, C.H. Sibley, S.A. Monks, P.A. Winstanley, and W.M. Watkins Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate pyrimethamine/ sulfadoxine compared with the shorter acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum J. Infect. Dis. 181 2000 2023 2028
24. R.E.L. Paul, M.J. Packer, M. Walmsley, M. Lagog, L.C. Ranford-Cartwright, R. Paru, and K.P. Day Mating patterns in malarial parasite populations of Papua New Guinea Science 269 1995 1709 1711
25. C.V. Plowe, J.F. Cortese, A. Djimde, O.C. Nwanyanwu, W.M. Watkins, P.A. Winstanley, J.G. EstradaFranco, R.E. Mollinedo, J.C. Avila, J.L. Cespedes, D. Carter, and O.K. Doumbo Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance J. Infect. Dis. 176 1997 1590 1596
26. C. Roper, R. Pearce, B. Bredenkamp, J. Gumede, C. Drakeley, F. Mosha, D. Chandramohan, and B. Sharp Antifolate antimalarial resistance in southeast Africa: a population-based analysis Lancet 361 2003 1174 1181
27. C. Roper, R. Pearce, S. Nair, B. Sharp, F. Nosten, and T. Anderson Intercontinental spread of pyrimethamine-resistant malaria Science 305 2004 1124
28. A.G. Schneider, Z. Premji, I. Felger, T. Smith, S. Abdulla, and H.-P.M.H. Beck A point mutation in codon 76 of pfcrt of P. falciparum is positively selected for by chloroquine treatment in Tanzania Infect. Genet. Evol. 1 2002 183 189
29. R. Shretta, J. Omumbo, B. Rapuoda, and R.W. Snow Using evidence to change antimalarial drug policy in Kenya Trop. Med. Int. Health 5 2000 755 764
30. C.H. Sibley, J.E. Hyde, P.F.G. Sims, C.V. Plowe, J.G. Kublin, E.K. Mberu, A.F. Cowman, P.A. Winstanley, W.M. Watkins, and A.M. Nzila Pyrimethamine- sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol. 17 2001 582 588
31. J. Sulo, P. Chimpeni, J. Hatcher, J.G. Kublin, C.V. Plowe, M.E. Molyneux, K. Marsh, T.E. Taylor, W.M. Watkins, and P.A. Winstanley Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial Lancet 360 2002 1136 1143
32. A.O. Talisuna, P. Langi, N. Bakyaita, T. Egwang, T.K. Mutabingwa, W. Watkins, E. Van Marck, and U. D'Alessandro Intensity of malaria transmission, antimalarial drug use and resistance in Uganda: what is the relationship between these three factors? Trans. R. Soc. Trop. Med. Hyg. 96 2002 310 317
33. A.O. Talisuna, P. Langi, T.K. Mutabingwa, E. Van Marck, N. Speybroeck, T.G. Egwang, W.W. Watkins, I.M. Hastings, and U. D'Alessandro Intensity of transmission and spread of gene mutations linked to chloroquine and sulphadoxine-pyrimethamine resistance in falciparum malaria Int. J. Parasitol. 33 2003 1051 1058
34. W.M. Watkins, E.K. Mberu, P.A. Winstanley, and C.V. Plowe The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses Parasitol. Today 13 1997 459 464
35. W.M. Watkins, and M. Mosobo Treatment of Plasmodium falciparum malaria with pyrimethamine-sulphadoxine: selective pressure for resistance is a function of long half-life Trans. R. Soc. Trop. Med. Hyg. 87 1993 75 78
36. N.J. White Antimalaria drug resistance and combination chemotherapy Philos. Trans. R. Soc. London Ser. B 354 1999 739 749
37. N.J. White, and W. Pongtavornpinyo The de novo selection of drug-resistant malaria parasites Proc. R. Soc. London Ser. B 270 2003 545 554
38. C. Wongsrichanalai, A.L. Pickard, W.H. Wernsdorfer, and S.R. Meshnick Epidemiology of drug-resistant malaria Lancet Infect. Dis. 2 2002 209 218
39. M.E.J. Woolhouse, C. Dye, J.-F. Etards, T. Smith, J.D. Charlwood, G.P. Garnett, P. Hagan, J.L.K. Hii, P.D. Ndhlovu, R.J. Quinell, C.H. Watts, S.K. Chandiwana, and R.M. Anderson Heterogeneities in the transmission of infectious agents: Implications for the design of control programs Proc. Natl. Acad. Sci. U.S.A. 94 1997 338 342
40. World Health Organisation, 2001. Antimalarial drug combination therapy. Report of a technical consultation. World Health Organisation, Geneva.